VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RKTO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RKTORocket One Inc.
$0.32$9M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
RKTO logo

Rocket One Inc.

RKTO
NASDAQ · Immunology Biotech
$0.32
At close - Nov 17, 4:00 PM EST - USD
Market Cap$8M
P/E-0.7x
52W High$2.45
Volume258.55K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Pre-Revenue Burn Persists Despite Ample Cash Cushion

Rocket One Inc. (RKTO) shows a pre-commercial immunology profile in which operating losses of $1.6M to $4.1M per quarter and operating cash burn of roughly $2M to $3M per quarter have persisted with only $35 of revenue reported in 2026Q3.

GrowthMixed
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

RKTO price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

6/12 Beats

EPS beat 6 of last 12 quarters

02

Valuation risk

-102% Peers

P/E is 102% below peer median

03

Market leadership

RS 10 · Lag

Laggard (Underperforming 90% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Feb 13

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
RKTO-69.95%
S&P 500 (^GSPC)+7.21%
1-Year Return
RKTO-72.52%
S&P 500 (^GSPC)+10.03%
3-Year Return
RKTO-70.29%
S&P 500 (^GSPC)+57.16%
5-Year Return
RKTO-98.62%
S&P 500 (^GSPC)+59.43%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
-
Net income FY25
-$12M-52.3% YoY
Free cash flow FY25
-$10M-40.5% YoY
Operating margin FY25
-
ROIC (FY25)-
Avg ROIC 5Y-17528.5%
ROE (TTM)-183.4%
Piotroski Score2 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate6/12 (50%)
Revenue Beat Rate0/12 (0%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 13, 2026
-$0.11+28.6%
vs -$0.15
$35+0.0%
vs $35
Q3 2026
Aug 14, 2026
-$0.19-33.4%
vs -$0.14
—
vs —
Q2 2026
May 15, 2026
-$0.17-23.4%
vs -$0.14
—
vs —
Q2 2026
Mar 27, 2026
-$0.16-55.2%
vs -$0.10
—
vs —
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

2 Stories
PRNewsWire·Nov 11, 2026
Rocket One's Tracer Drone Secures Public Safety Wins Across Four Law Enforcement Agencies, Two Sheriff's Departments and Two Fire Departments

Following acquisition, Tracer Drone accelerates fleet expansion and operational readiness, with services spanning pilot certification preparation to turnkey Drone as First Responder systems. HOBOKEN, N.J.

PRNewsWire·Nov 3, 2026
Rocket One's Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Patients

Positive interim findings drive early trial conclusion; Hoth prepares to seek FDA alignment on a potential pivotal study for cancer treatment–related skin toxicity HOBOKEN, N.J., Nov. 3, 2026 /PRNewswire/ -- Rocket One Inc. (Nasdaq: RKTO) ("Rocket One" or the "Company") today announced that its biotechnology subsidiary, Hoth Therapeutics, has decided to end its Phase 2a clinical trial of HT-001 early following strong interim efficacy results.

Filtered for Rocket One Inc.More Headlines
04

Compare before deciding

Benchmark RKTO against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Rocket One Inc. (RKTO)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
RKTO logoRKTORocket One Inc.Current
$0.32$7.83M-0.66—-33984280%-183.44%—
CLOV logoCLOVClover Health Investments, Corp.
$4.73$2.45B212.1140.34%0.45%3.52%—
XTLB logoXTLBXTL Biopharmaceuticals Ltd.
$1.62$712.96K-0.10-100%———
NRXP logoNRXPNRx Pharmaceuticals, Inc.
$2.45$42.35M-5.35—-458.48%——
BFRI logoBFRIBiofrontera Inc.
$0.59$7.6M-1.4811.8%-12.72%-110.3%—
SKIN logoSKINSkinHealth Systems Inc.
$13.88$90.43M-4.95-10.02%-6.33%-32.09%—

Compare RKTO vs Peers

Rocket One Inc. (RKTO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CLOV

Most directly comparable listed peer for RKTO.

Scale Benchmark

vs ABBV

Larger-name benchmark to compare RKTO against a more recognizable public peer.

Peer Set

Compare Top 5

vs CLOV, XTLB, NRXP, BFRI

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

RKTO SEC Filings & Documents

Rocket One Inc. (RKTO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Sep 25, 2026·SEC

Material company update

Sep 22, 2026·SEC

Material company update

Aug 11, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 27, 2026·SEC

FY 2025

Mar 28, 2025·SEC

FY 2024

Mar 28, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Nov 13, 2026·SEC

FY 2026

Aug 14, 2026·SEC

FY 2026

May 15, 2026·SEC

Get notified when RKTO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

RKTO Frequently Asked Questions

Rocket One Inc. (RKTO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Rocket One Inc.'s revenue?

Rocket One Inc. (RKTO) reported $0.0M in revenue over the trailing twelve months.

Is RKTO profitable?

No. Rocket One Inc. (RKTO) reported a net loss of $11.9M over the trailing twelve months.

Dividend & Returns
What is RKTO's return on equity?

Rocket One Inc. (RKTO) had a return on equity (ROE) of -183.4% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is Rocket One Inc.'s free cash flow?

Rocket One Inc. (RKTO) had negative free cash flow of $11.0M over the trailing twelve months.

What if you invested $1,000 in RKTO back in 2017?

Total return calculator · dividends reinvested · 9+ years of data

See returns →